Skip to main content

Table 3 Mean change from baseline to Week 25 in WOMAC index scores

From: Intra-articular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the asian population

WOMAC section

Hyalgan®(n = 100)

Placebo (n = 98)

p value

Pain

   

Change from W0 to W25, mm (SE)

29.28 (1.92)

21.52 (1.94)

0.0050*

Stiffness

   

Change from W0 to W25, mm (SE)

24.85 (2.18)

22.58 (2.21)

0.4640

Function

   

Change from W0 to W25, mm (SE)

25.16 (1.67)

18.20 (1.69)

0.0038*

  1. SE, standard error of mean.
  2. *P < 0.05, indicated significantly different between treatment groups.
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us